Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript

SA Transcripts 162.17K Followers Follow Agenus Inc. ( AGEN ) Shareholder/Analyst Call September 10, 2026 4:30 PM EDT Company Participants Stefanie Perna-Nacar - Chief Communications & Government Relations Officer Garo Armen - Founder, Interim CFO, Principal Financial Officer, CEO & Executive Chairman Steven O’Day - Chief Medical Officer Robin Taylor - Chief Commercial Officer Dhan Chand Conference Call Participants Benjamin L. Schlechter Presentation Stefanie Perna-Nacar Chief Communications & Government Relations Officer Good evening, everyone, and thank you for joining us today. My name is Stefanie Nacar, and I'm Chief Communications Officer here at Agenus, and welcome to our September Stakeholder Webcast. Joining me today are Garo Armen, our Chairman and Chief Executive Officer; Dr. Steven O'Day, our Chief Medical Officer; and we'll also hear from Dr. Benjamin Schlechter of the Dana-Farber Cancer Institute. Our discussion today will focus on the progress that we've made since our July webcast, including implementation of the ROBBIN Phase III neoadjuvant program, continued physician interest in the access to BOT+BAL and recent clinical and investigator-led activity that is helping inform the acceleration of BOT+BAL into the earlier disease settings. Following the prepared discussion, Agenus leadership, including Dr. O'Day as well as Robin Taylor, Chief Commercial Officer, will join Garo for a live Q&A. Questions may be submitted at any time during the webcast using the Q&A function of the Zoom event below. Before we begin, just a brief reminder that today's discussion includes forward-looking statements, so please be sure to refer to our SEC filings for additional details also available on our website. With that, I'm pleased to introduce our Founder, Chairman and CEO, Garo Armen. Garo Armen Founder, Interim CFO, Principal Financial Officer, CEO & Executive Chairman Thank you very much, Stefanie, and thank you, everyone, for joining us today. When we had this session back in July, we spoke about the financing that was announced then. And we also spoke